Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'OLENCKI T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tate, J; Olencki, T; Finke, J; Kottke-Marchant, K; Rybicki, LA; Bukowski, RM
      Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects

      ANNALS OF ONCOLOGY
    2. Olencki, T; Peereboom, D; Wood, L; Budd, GT; Novick, A; Finke, J; McLain, D; Elson, P; Bukowski, RM
      Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    3. Olencki, T; Finke, J; Tubbs, R; Elson, P; McLain, D; Herzog, P; Budd, GT; Gunn, H; Bukowski, RM
      Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects

      JOURNAL OF IMMUNOTHERAPY
    4. Pelley, R; Ganapathi, R; Wood, L; Rybicki, L; McLain, D; Budd, GT; Peereboom, D; Olencki, T; Bukowski, RM
      A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Olencki, T; Bukowski, RM
      Interleukin-2 in metastatic renal cell carcinoma

      RENAL CELL CARCINOMA
    6. Bukowski, RM; Rayman, P; Molto, L; Tannenbaum, CS; Olencki, T; Peereboom, D; Tubbs, R; McLain, D; Budd, GT; Griffin, T; Novick, A; Hamilton, TA; Finke, J
      Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma

      CLINICAL CANCER RESEARCH
    7. MOTZER RJ; RAKHIT A; SCHWARTZ LH; OLENCKI T; MALONE TM; SANDSTROM K; NADEAU R; PARMAR H; BUKOWSKI R
      PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA

      Clinical cancer research
    8. MOTZER RJ; RAKHIT A; SCHWARTZ LH; OLENCKI T; MALONE TM; SANDSTROM K; NADEAU R; PARMAR H; BUKOWSKI R
      PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA

      Clinical cancer research
    9. BUKOWSKI RM; RAYMAN P; UZZO R; BLOOM T; SANDSTROM K; PEEREBOOM D; OLENCKI T; BUDD GT; MCLAIN D; ELSON P; NOVICK A; FINKE JH
      SIGNAL-TRANSDUCTION ABNORMALITIES IN T-LYMPHOCYTES FROM PATIENTS WITHADVANCED RENAL-CARCINOMA - CLINICAL RELEVANCE AND EFFECTS OF CYTOKINETHERAPY

      Clinical cancer research
    10. BUKOWSKI RM; OLENCKI T; BOCOCK K; BUDD GT; PEEREBOOM D; MCLAIN D; GRIFFIN T
      PHASE-I TRIAL OF CAPECITABINE AND SUBCUTANEOUS INTERFERON-ALPHA IN RENAL-CELL CARCINOMA (RCC)

      Annals of oncology
    11. Rajagopalan, K; Peereboom, D; Budd, GT; Olencki, T; Murthy, S; Elson, P; McLain, D; Bukowski, R
      Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer

      INVESTIGATIONAL NEW DRUGS
    12. WARD AM; OLENCKI T; PEERBOOM D; KLEIN EA
      SHOULD CONTINENT DIVERSION BE PERFORMED IN PATIENTS WITH LOCALLY ADVANCED BLADDER-CANCER

      Urology
    13. PIENKNY AJ; NOVICK AC; PLAUTZ GE; OLENCKI T; SANDSTROM K; BUKOWSKI RM; SHU S
      PHASE-I TRIAL OF ADOPTIVE IMMUNOTHERAPY FOR METASTATIC RENAL-CELL CARCINOMA WITH ACTIVATED LYMPH-NODE T-LYMPHOCYTES

      The Journal of urology
    14. BUKOWSKI RM; OLENCKI T; WANG Q; PEEREBOOM D; BUDD GT; ELSON P; SANDSTROM K; TUASON L; RAYMAN P; TUBBS R; MCLAIN D; KLEIN E; NOVICK A; FINKE J
      PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE

      Journal of immunotherapy with emphasis on tumor immunology
    15. BUDD GT; GANAPATHI R; ADELSTEIN DJ; PELLEY R; OLENCKI T; PETRUS J; MCLAIN D; ZHANG JL; CAPIZZI R; BUKOWSKI RM
      RANDOMIZED TRIAL OF CARBOPLATIN PLUS AMIFOSTINE VERSUS CARBOPLATIN ALONE IN PATIENTS WITH ADVANCED SOLID TUMORS

      Cancer
    16. BUKOWSKI RM; OLENCKI T; GUNN H; MCLAIN D; BUDD GT; SANDSTROM K; TUASON L; REDOVAN C; RAYMAN P; TUBBS R; RESTA D; ELSON P; FINKE J
      PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS

      Clinical cancer research
    17. OLENCKI T; FINKE J; TUBBS R; TUASON L; GREENE T; MCLAIN D; SWANSON SJ; HERZOG P; STANLEY T; EDINGER M; BUDD GT; BUKOWSKI RM
      IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-4 IN PATIENTS WITH MALIGNANCY

      Journal of immunotherapy with emphasis on tumor immunology
    18. WOS E; OLENCKI T; TUASON L; BUDD GT; PEEREBOOM D; SANDSTROM K; MCLAIN D; FINKE J; BUKOWSKI RM
      PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

      Cancer
    19. BUKOWSKI RM; DON W; REDOVAN C; MCLAIN D; SANDSTROM K; OLENCKI T; BUDD GT; PEEREBOOM D; GRIFFIN T; TANNENBAUM C; FINKE JK
      INDUCTION OF THE CXC CHEMOKINES IP-10 AND MIG IN PATIENTS (PTS) RECEIVING RHUIL-12 OR RIL-2

      Blood
    20. WANG Q; REDOVAN C; TUBBS R; OLENCKI T; KLEIN E; KUDOH S; FINKE J; BUKOWSKI RM
      SELECTIVE CYTOKINE GENE-EXPRESSION IN RENAL-CELL CARCINOMA TUMOR-CELLS AND TUMOR-INFILTRATING LYMPHOCYTES

      International journal of cancer
    21. OLENCKI T; FINKE J; BUKOWSKI RM
      INTERLEUKIN-6 - POTENTIAL CLINICAL-APPLICATIONS IN CANCER-THERAPY

      CLINICAL IMMUNOTHERAPEUTICS
    22. BUKOWSKI RM; MURTHY SA; FINKE J; CAULFIELD MJ; TUBBS R; HERZOG P; STANLEY J; EDINGER M; TUASON L; MCLAIN D; BUDD GT; OLENCKI T; GANAPATHI R
      PHASE-I TRIAL OF CISPLATIN, WR-2721, AND THE MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND BIOLOGIC EFFECTS

      Journal of immunotherapy with emphasis on tumor immunology
    23. BUKOWSKI RM; OLENCKI T; MCLAIN D; FINKE JH
      PLEIOTROPIC EFFECTS OF CYTOKINES - CLINICAL AND PRECLINICAL STUDIES

      Stem cells
    24. BUDD GT; LORENZI V; GANAPATHI R; ADELSTEIN D; PELLEY R; OLENCKI T; MCLAIN D; BUKOWSKI RM
      AMIFOSTINE - POTENTIAL FOR CLINICALLY USEFUL CYTOPROTECTION

      Supportive care in cancer
    25. BUKOWSKI RM; OLENCKI T; MCLAIN D; TUASON L; BUDD GT; SANDSTROM K; RAYMAN P; GUNN H; LEVITT D; FINKE J
      PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT INTERLEUKIN-3 (RHIL-3) FOLLOWING SUBCUTANEOUS (SQ) ADMINISTRATION TO PATIENTS WITH REFRACTORY MALIGNANCIES

      Blood
    26. WOS E; OLENCKI T; BUDD GT; PEEREBOOM D; FINKE J; WOOD L; MCLAIN D; TUBBS R; REDOVAN C; EDINGER M; LEVITT D; BUKOWSKI RM
      HEMATOLOGIC EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHUGM-CSF) AND INTERLEUKIN-6 (RHIL-6) ADMINISTERED TO PATIENTS WITH MALIGNANCY

      Blood
    27. OLENCKI T; BUDD GT; MURTHY S; FINKE J; HERZOG P; MCLAIN D; TUBBS R; TUASON L; EDINGER M; LEVITT D; BUKOWSKI RM
      CYTOKINE GENE-EXPRESSION AND SECRETION - EFFECTS OF RHIL-6 IN CANCER-PATIENTS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 08:41:22